tryptophan has been researched along with Carcinoma, Non-Small Cell Lung in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 14 (53.85) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Dong, B; Dong, Y; Guo, G; Hou, Z; Jiang, H; Li, H; Li, J; Li, X; Sun, Z; Wang, Y; Xue, X; Yang, JH; Yang, Y; Zhang, A; Zhang, G; Zhang, L; Zhu, Q | 1 |
| Azuma, K; Hoshino, T; Imaizumi, A; Ishii, H; Karakawa, S; Kasajima, R; Kato, Y; Kawahara, A; Kikuchi, S; Matsuo, N; Miyagi, Y; Murotani, K; Sasada, T; Tagami, T; Tokito, T; Xiang, H | 1 |
| Cao, B; Feng, H; Peng, X; Wei, Q | 1 |
| Bi, N; Chen, Y; Qian, M; Wang, D; Wang, L; Wu, L; Xu, X; Zhang, T | 1 |
| DI, LQ; Huang, X; Lu, YY; Luo, ZC; Qi, MY; Shan, JJ; Zhang, W | 1 |
| Bai, Y; Chen, F; Ma, J; Wang, D; Xue, P; Zhang, L; Zhou, F | 1 |
| Cao, B; Fei, F; Jiang, J; Jin, D; Li, J; Sun, R; Wang, M; Xu, Z; Yang, G; Yang, N | 1 |
| Bessede, A; Cabart, M; Chomy, F; Cousin, S; Guegan, JP; Italiano, A; Lara, O; Le Moulec, S; Nafia, I; Odin, O; Peyraud, F; Rey, C | 1 |
| Bader, B; Batra, AS; Baumann, D; Carretero, R; Cichon, F; Elmadany, N; Gorjánácz, M; Gutcher, I; Hartung, IV; Irlbacher, H; Kober, C; Kreft, B; Leder, G; Lefranc, J; Lesche, R; Oezcan-Wahlbrink, M; Oezen, I; Offringa, R; Olesch, C; Opitz, CA; Platten, M; Prinz, F; Roehn, U; Roese, L; Roewe, J; Roider, HG; Sadik, A; Sahm, K; Schmees, N; Stoeckigt, D; Weinmann, H | 1 |
| Ambrosino, S; Belladonna, ML; De Marchis, F; Gargaro, M; Mandarano, M; Mondanelli, G; Orabona, C; Pallotta, MT; Panfili, E; Rossini, S; Suvieri, C; Volpi, C | 1 |
| Enomoto, N; Fujisawa, T; Furuhashi, K; Hozumi, H; Inui, N; Karayama, M; Maekawa, M; Masuda, J; Mori, K; Nakamura, Y; Suda, T; Sugimura, H; Suzuki, Y; Takada, A; Yasui, H | 1 |
| An, C; Cho, SY; Chung, H; Jang, M; Jeon, BN; Jeong, JJ; Kim, G; Kim, H; Kim, HS; Kim, S; Kim, SG; Kim, Y; Kim, YY; Kwon, JY; Lee, C; Lee, EJ; Lee, GB; Lee, S; Lee, SH; Moon, MH; Nam, MH; Park, C; Park, H; Park, JS; Sohn, J; Weinstock, GM; Won, S; Yang, HS; Yoon, KW; Yoon, Y | 1 |
| Baglivo, S; Belladonna, ML; Bellezza, G; Chiari, R; Loreti, E; Ludovini, V; Mandarano, M; Orecchini, E; Puma, F; Sidoni, A; Tofanetti, FR; Vannucci, J | 1 |
| Cai, J; Cao, Y; Fan, X; Fu, Y; Hsiao, WW; Huang, J; Jiang, Z; Khan, I; Lai, H; Leung, EL; Li, J; Li, R; Liao, J; Liu, D; Liu, H; Liu, L; Liu, Z; Lu, J; Luo, L; Shi, A; Wang, L; Wang, W; Wang, Y; Wei, H; Wu, J; Wu, Q; Xie, Y; Yan, P; Yang, M; Yao, X; Yuan, J; Zhang, Y | 1 |
| Huang, L; Jin, JY; Jolly, S; Kong, FS; Li, L; Mellor, AL; Pi, W; Wang, W; Wu, H; Yan, L; Zang, Y | 1 |
| Botticelli, A; Cerbelli, B; Federica, M; Lionetto, L; Marchetti, P; Nuti, M; Pisano, A; Salati, M; Simmaco, M; Zizzari, I | 1 |
| Andersen, MH; Andersen, R; Bjoern, J; Ellebaek, E; Engell-Noerregaard, L; Gouttefangeas, C; Holm, B; Iversen, TZ; Larsen, SK; Mellemgaard, A; Svane, IM; Thomsen, BM; Thor Straten, P; Zeyher, C | 1 |
| Ametamey, SM; Chiotellis, A; Keller, C; Krämer, SD; Mu, L; Müller, A; Schibli, R; Selivanova, SV | 1 |
| Armutlulu, A; Balaram, H; Balasubramanian, S; Bartosh, TJ; Broda, M; Brown, LE; Burroughs, LM; Burrows, F; Cardoso, JR; Carregaro, RL; Cho, J; Cui, Q; Dela Bela, LF; Dias, JM; Dutta, NK; Flowers, ME; Gallo, S; Hari, P; He, R; He, Y; Heimfeld, S; Jia, B; Jin, X; Jin, YJ; Karakousis, PC; Karmakar, T; Kiem, HP; Kreager, DA; Lebedev, D; Li, F; Li, S; Liang, N; Liu, Z; Luo, J; Luo, Y; Mazuquin, BF; Meng, Y; Mosialos, G; Moura, FA; Müller, CR; Naeem, MA; Nagappa, LK; Nguyen, H; Pelegrinelli, AR; Pinn, ML; Prahlada Rao, VS; Pulsipher, MA; Ragan, DT; Richards, J; Roy, S; Sandmaier, BM; Selfe, J; Selim, MA; Shi, J; Shi, X; Staff, J; Storb, R; Storer, BE; Wang, F; Wang, M; Wang, S; Woolfrey, AE; Wright, T; Ylostalo, JH; Zhang, JY; Zhang, ZY; Zheng, K; Zhu, Z | 1 |
| Cheng, X; Hao, H; Li, Q; Liu, F; Liu, H; Wang, G; Wang, H; Xing, R; Ye, H; Zhao, M | 1 |
| Chakraborty, PK; Chugani, DC; Jahania, MS; Juhász, C; Khalaf, M; Lu, X; Mangner, TJ; Muzik, O; Peng, F; Soubani, AO | 1 |
| Engin, AB; Fuchs, D; Ozkan, Y; Yardim-Akaydin, S | 1 |
| Hu, B; Hu, S; Shen, G; Xu, W; Yin, S | 1 |
| Hu, B; Hu, SL; Shen, G; Wang, H; Wang, WD; Xu, WP; Yin, S; Zhang, Q | 1 |
| de Villiers, EM; Fei, JW | 1 |
| Blanck, G; Eason, DD; Shepherd, AT | 1 |
2 trial(s) available for tryptophan and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Cancer Vaccines; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kaplan-Meier Estimate; Kynurenine; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Statistics, Nonparametric; T-Lymphocytes, Regulatory; Treatment Outcome; Tryptophan; Vaccination | 2014 |
[The effect of amino acid nutritional support on serum tryptophan and melatonin in lung cancer patients receiving chemotherapy].
Topics: Aged; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Melatonin; Neoplasm Staging; Parenteral Nutrition; Treatment Outcome; Tryptophan; Vinblastine; Vinorelbine | 2006 |
24 other study(ies) available for tryptophan and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Open Search-Based Proteomics Reveals Widespread Tryptophan Modifications Associated with Hypoxia in Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Hypoxia; Lung Neoplasms; Proteome; Proteomics; Tryptophan | 2022 |
Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model.
Topics: Amino Acids; Arginine; Carcinoma, Non-Small-Cell Lung; Glycine; Humans; Immune Checkpoint Inhibitors; Leukocytes, Mononuclear; Lung Neoplasms; Neopterin; Pilot Projects; Prognosis; Quinolinic Acids; Tryptophan | 2022 |
Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer.
Topics: Cancer-Associated Fibroblasts; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Receptors, Aryl Hydrocarbon; Tryptophan; Tumor Microenvironment | 2022 |
Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lung Neoplasms; Tryptophan | 2022 |
[Mechanism of Cordyceps militaris against non-small cell lung cancer: based on serum metabolomics].
Topics: Alanine; Animals; Arginine; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cordyceps; Glutamic Acid; Glutamine; Glyoxylates; Humans; Lung Neoplasms; Metabolomics; Mice; Mice, Nude; Nitrogen; Phenylalanine; RNA, Transfer; Tryptophan; Tyrosine | 2022 |
MicroRNA-185-5p targets tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta to regulate non-small cell lung cancer progression.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Luciferases; Lung Neoplasms; MicroRNAs; Tryptophan; Tyrosine 3-Monooxygenase | 2023 |
Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non-small cell lung cancer.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Chromatography, Liquid; Humans; Lung Neoplasms; Pemetrexed; Pyruvates; Tandem Mass Spectrometry; Tryptophan | 2023 |
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer.
Topics: B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lung Neoplasms; Tertiary Lymphoid Structures; Tryptophan; Up-Regulation | 2023 |
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Dioxygenases; Head and Neck Neoplasms; Humans; Immunologic Factors; Immunotherapy; Kynurenine; Leukocytes, Mononuclear; Lung Neoplasms; Mice; Receptors, Aryl Hydrocarbon; Squamous Cell Carcinoma of Head and Neck; Tryptophan; Tumor Microenvironment | 2023 |
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lung Neoplasms; Phosphorylation; Tryptophan | 2023 |
Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer.
Topics: 3-Hydroxyanthranilic Acid; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Biomarkers; Carcinoma, Non-Small-Cell Lung; Female; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Male; Middle Aged; Progression-Free Survival; Prospective Studies; Regression Analysis; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Tryptophan; Xanthurenates | 2021 |
Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice.
Topics: Animals; Bifidobacterium bifidum; Carcinoma, Non-Small-Cell Lung; Drug Therapy, Combination; Gastrointestinal Microbiome; Humans; Immune Checkpoint Inhibitors; Interferon-gamma; Lung Neoplasms; Metabolome; Mice; Neoplasms, Experimental; Probiotics; Species Specificity; Transcriptome; Tryptophan; Tumor Burden | 2021 |
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tryptophan | 2021 |
Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Cell Death; Gastrointestinal Microbiome; Humans; Immunologic Factors; Immunotherapy; Kynurenine; Ligands; Lung Neoplasms; Mice; Panax; Polysaccharides; Tryptophan | 2022 |
IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Female; Follow-Up Studies; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lung Neoplasms; Male; Prognosis; Prospective Studies; Survival Rate; Tryptophan | 2018 |
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kaplan-Meier Estimate; Kynurenine; Lung Neoplasms; Male; Multivariate Analysis; Programmed Cell Death 1 Receptor; Quinolinic Acid; Tryptophan | 2018 |
Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Contrast Media; Fluorine Radioisotopes; Humans; Lung Neoplasms; Mice; Mice, Inbred Strains; Mice, Nude; Molecular Structure; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tryptophan | 2013 |
Topics: Adolescent; Adult; Age Factors; Aged; Amino Acid Substitution; Anemia, Aplastic; Athletes; Athletic Performance; Bone Marrow Transplantation; Carcinoma, Non-Small-Cell Lung; Catalytic Domain; Cell Count; Child; Child, Preschool; Escherichia coli; Female; Gene Expression; Graft Survival; Graft vs Host Disease; Histocompatibility Testing; Humans; Hydrogen Bonding; Immunosuppression Therapy; Inosine Monophosphate; Integrin alphaVbeta3; Kinetics; Knee Joint; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Molecular Dynamics Simulation; Muscle, Skeletal; Mutation; Organotechnetium Compounds; Pentosyltransferases; Peptides, Cyclic; Phenylalanine; Plasmodium falciparum; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Protozoan Proteins; Radiopharmaceuticals; Recombinant Proteins; Running; Sensitivity and Specificity; Serine; Siblings; Single Photon Emission Computed Tomography Computed Tomography; Soccer; Structure-Activity Relationship; Substrate Specificity; Thermodynamics; Threonine; Time Factors; Torque; Treatment Outcome; Tryptophan; Tyrosine; Young Adult | 2016 |
De-novo NAD+ synthesis regulates SIRT1-FOXO1 apoptotic pathway in response to NQO1 substrates in lung cancer cells.
Topics: A549 Cells; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Forkhead Box Protein O1; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Lung Neoplasms; Mice; Mice, Nude; NAD; NAD(P)H Dehydrogenase (Quinone); Neoplasm Transplantation; Oxidative Stress; Oxygen; Signal Transduction; Sirtuin 1; Tryptophan | 2016 |
Quantification of tryptophan transport and metabolism in lung tumors using PET.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tryptophan | 2009 |
Increased tryptophan degradation in patients with bronchus carcinoma.
Topics: Blood Sedimentation; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Male; Middle Aged; Neoplasm Proteins; Neopterin; Pilot Projects; Small Cell Lung Carcinoma; Tryptophan | 2010 |
Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Circadian Rhythm; Female; Humans; Lung Neoplasms; Male; Melatonin; Middle Aged; Tryptophan | 2009 |
Degradation of HPV20E6 by p53: Delta Np63 alpha and mutant p53R248W protect the wild type p53 mediated caspase-degradation.
Topics: Apoptosis; Arginine; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; DNA-Binding Proteins; Glutathione Transferase; Humans; Immunoprecipitation; Lung Neoplasms; Mass Spectrometry; Mutation; Oncogene Proteins, Viral; Papillomavirus Infections; Trans-Activators; Transcription Factors; Tryptophan; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Tumor Virus Infections; Ubiquitin; Vimentin | 2008 |
Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding.
Topics: Arginine; Carcinoma, Non-Small-Cell Lung; DNA-Binding Proteins; Electrophoresis; Humans; Interferon Regulatory Factor-1; Lung Neoplasms; Phosphoproteins; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transcription, Genetic; Transfection; Tryptophan; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1999 |